Metraipolis › archive › dc_da95329fea96
Pan-cancer analysis identifies APOC1 as a TAM-derived modulator of adaptive immune resistance and predictor of therapeutic response — Europe PMC PMID:42348034
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42348034
- DOI
- 10.1007/s12672-[numero omesso]-x
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T13:15:22.513Z
- SHA-256 of the archived text
2c36866dcad4fd8a56443c22b186725cc204010f40a3d891855efc376c1b4306- Stable URL of this page
https://metraipolis.com/documento/dc_da95329fea96
How to cite
Pan-cancer analysis identifies APOC1 as a TAM-derived modulator of adaptive immune resistance and predictor of therapeutic response — Europe PMC PMID:42348034 — Europe PMC (en), https://europepmc.org/article/MED/42348034 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_da95329fea96 (Metraipolis archive dc_da95329fea96, sha256 2c36866dcad4fd8a56443c22b186725cc204010f40a3d891855efc376c1b4306)
BibTeX
@misc{dcda95329fea96,
title = {Pan-cancer analysis identifies APOC1 as a TAM-derived modulator of adaptive immune resistance and predictor of therapeutic response — Europe PMC PMID:42348034},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42348034},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_da95329fea96; sha256 2c36866dcad4fd8a56443c22b186725cc204010f40a3d891855efc376c1b4306},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42348034. Agents can read the archived copy with the MCP tool read_document.